• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 15 of 20
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance
Biotech Stocks Are Down 25% So Far This Year
By Sy MukherjeeMay 6, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
Finance
These Biopharma Companies Are the World’s Top Shareholder Value Creators
By Sy MukherjeeMay 3, 2016
Celebrities At The Los Angeles Lakers Game
Finance
This Doctor Was Likely America’s Best Paid CEO in 2015
By Lucinda ShenApril 28, 2016
96436978
Tech
Why Microsoft Just Bought 10 Million Strands of DNA
By David MeyerApril 28, 2016
547016547
Health
Why Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop
By Sy MukherjeeApril 27, 2016
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
Health
This Rare Children’s Disease Drug Is Pitting Patients Against the FDA
By Sy MukherjeeApril 26, 2016
Trading On The Floor Of The NYSE As U.S. Stocks Rise With Oil After Best Weekly Gain Since November
Finance
Here’s Why Biogen’s Shares Are Climbing Today
By Sy MukherjeeApril 21, 2016
Here’s Why This Genetics Biotech’s Stock Plunged Today
Finance
Here’s Why This Genetics Biotech’s Stock Plunged Today
By Sy MukherjeeApril 19, 2016
Nick Annetta, right, of Battelle, watches as Ian Burkhart, 24, plays a guitar video game using his paralyzed hand. A computer chip in Burkhart`s brain reads his thoughts, decodes them, then sends signals to a sleeve on his arm, that allows him to move his hand.
Health
This Incredible Technology Let a Paralyzed Man Move His Hand
By Sy MukherjeeApril 14, 2016
BELGIUM-EU-AGRICULTURE-POLITICS
Health
FDA Says Pig Drug not Kosher Afterall
By ReutersApril 8, 2016
Key Speakers At The Hedge Funds Summit
Finance
Olive Garden Investor’s New Stock Pick Is This Biotech
By ReutersApril 8, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Health
Samsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push
By ReutersApril 4, 2016
The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs
Health
The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs
By ReutersMarch 29, 2016
Kim Le, a research associate for FivePrime Therapeutics, wor
Health
Affymetrix Rejects Rival Bid, Supports Thermo Fisher Merger
By ReutersMarch 20, 2016
503920324
Finance
The Hottest IPO of 2016 Is Crashing
By Sy MukherjeeMarch 9, 2016
1...
  • 13
  • 14
  • 15
  • 16
  • 17
...20
Most Popular
Middle East
The emerging deal to reopen the Strait of Hormuz reportedly recognizes Iran’s control—and the U.S. may have to accept itplaceholder alt text
By Jason MaAugust 7, 2026
Economy
How Scott Bessent used financial engineering to finance the $2 trillion deficit while leaving it untouched—and created a $1.45 trillion shortfallplaceholder alt text
By Eva RoytburgAugust 8, 2026
Real Estate
The tables have turned: Florida and Texas are the biggest losers in the housing market as Ohio emerges a surprise winnerplaceholder alt text
By Sydney LakeAugust 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.